Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,622 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Introduction of a carboxylic acid group into pyrazolylpyridine derivatives increased selectivity for inhibition of the 20-HETE synthase CYP4A11/4F2.
Kawamura M, Kobashi Y, Tanaka H, Bohno-Mikami A, Hamada M, Ito Y, Suzuki K, Funayama K, Hirata T, Ohara H, Koretsune H, Kojima N, Fukunaga T, Hirate M, Inatani S, Hasegawa Y, Takahashi T, Kakinuma H. Kawamura M, et al. Bioorg Med Chem. 2023 Oct 18;95:117505. doi: 10.1016/j.bmc.2023.117505. Online ahead of print. Bioorg Med Chem. 2023. PMID: 39491277
Discovery of Novel Pyrazolylpyridine Derivatives for 20-Hydroxyeicosatetraenoic Acid Synthase Inhibitors with Selective CYP4A11/4F2 Inhibition.
Kawamura M, Kobashi Y, Tanaka H, Bohno-Mikami A, Hamada M, Ito Y, Hirata T, Ohara H, Kojima N, Koretsune H, Gunji E, Fukunaga T, Inatani S, Hasegawa Y, Suzuki A, Takahashi T, Kakinuma H. Kawamura M, et al. J Med Chem. 2022 Nov 10;65(21):14599-14613. doi: 10.1021/acs.jmedchem.2c01089. Epub 2022 Nov 1. J Med Chem. 2022. PMID: 36318660
Synthesis and Structure-Activity Relationship of C-Phenyl D-Glucitol (TP0454614) Derivatives as Selective Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitors.
Kuroda S, Kobashi Y, Kawamura M, Kawabe K, Shiozawa F, Hamada M, Shimizu Y, Okumura-Kitajima L, Koretsune H, Kimura K, Yamamoto K, Kakinuma H. Kuroda S, et al. Among authors: kawamura m. Chem Pharm Bull (Tokyo). 2020;68(7):635-652. doi: 10.1248/cpb.c20-00089. Chem Pharm Bull (Tokyo). 2020. PMID: 32611999 Free article.
Isoquinoline derivatives as potent CRTH2 antagonists: design, synthesis and SAR.
Nishikawa-Shimono R, Sekiguchi Y, Koami T, Kawamura M, Wakasugi D, Watanabe K, Wakahara S, Kimura K, Yamanobe S, Takayama T. Nishikawa-Shimono R, et al. Among authors: kawamura m. Bioorg Med Chem. 2013 Dec 15;21(24):7674-85. doi: 10.1016/j.bmc.2013.10.025. Epub 2013 Oct 30. Bioorg Med Chem. 2013. PMID: 24216094
Isoquinoline derivatives as potent CRTH2 receptor antagonists: synthesis and SAR.
Nishikawa-Shimono R, Sekiguchi Y, Koami T, Kawamura M, Wakasugi D, Watanabe K, Wakahara S, Matsumoto K, Takayama T. Nishikawa-Shimono R, et al. Among authors: kawamura m. Bioorg Med Chem Lett. 2012 May 1;22(9):3305-10. doi: 10.1016/j.bmcl.2012.03.009. Epub 2012 Mar 10. Bioorg Med Chem Lett. 2012. PMID: 22469703
Isoquinoline derivatives as potent, selective, and orally active CRTH2 antagonists.
Nishikawa-Shimono R, Sekiguchi Y, Kawamura M, Wakasugi D, Kawanishi M, Watanabe K, Asakura Y, Takaoka A, Takayama T. Nishikawa-Shimono R, et al. Among authors: kawamura m. Chem Pharm Bull (Tokyo). 2014;62(6):528-37. doi: 10.1248/cpb.c13-00980. Chem Pharm Bull (Tokyo). 2014. PMID: 24881658 Free article.
2,622 results